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ABSTRACT
Objective Neonatal encephalopathy (NE) is the third 
leading cause of child mortality. Preclinical studies 
suggest infection and inflammation can sensitise or 
precondition the newborn brain to injury. This study 
examined perinatal risks factor for NE in Uganda.
Design Unmatched case–control study.
Setting Mulago National Referral Hospital, Kampala, 
Uganda.
Methods 210 term infants with NE and 409 unaffected 
term infants as controls were recruited over 13 months. 
Data were collected on preconception, antepartum and 
intrapartum exposures. Blood culture, species-specific 
bacterial real-time PCR, C reactive protein and placental 
histology for chorioamnionitis and funisitis identified 
maternal and early newborn infection and inflammation. 
Multivariable logistic regression examined associations 
with NE.
Results Neonatal bacteraemia (adjusted OR (aOR) 
8.67 (95% CI 1.51 to 49.74), n=315) and histological 
funisitis (aOR 11.80 (95% CI 2.19 to 63.45), n=162) 
but not chorioamnionitis (aOR 3.20 (95% CI 0.66 to 
15.52), n=162) were independent risk factors for NE. 
Among encephalopathic infants, neonatal case fatality 
was not significantly higher when exposed to early 
neonatal bacteraemia (OR 1.65 (95% CI 0.62 to 4.39), 
n=208). Intrapartum antibiotic use did not improve 
neonatal survival (p=0.826). After regression analysis, 
other identified perinatal risk factors (n=619) included 
hypertension in pregnancy (aOR 3.77), male infant (aOR 
2.51), non-cephalic presentation (aOR 5.74), lack of 
fetal monitoring (aOR 2.75), augmentation (aOR 2.23), 
obstructed labour (aOR 3.8) and an acute intrapartum 
event (aOR 8.74).
Conclusions Perinatal infection and inflammation 
are independent risk factors for NE in this low-resource 
setting, supporting a role in the aetiological pathway of 
term brain injury. Intrapartum antibiotic administration 
did not mitigate against adverse outcomes. The 
importance of intrapartum risk factors in this sub-
Saharan African setting is highlighted.
InTRODuCTIOn
Birth complications and perinatal infections are 
leading contributors to neonatal mortality globally.1 
Each year, peripartum complications contribute to 
more than one million cases of neonatal encepha-
lopathy (NE) and around half a million survivors 
with neurological impairment.2 In sub-Saharan 
Africa, where access to skilled birth attendants and 
emergency obstetric intervention is often limited, 
the contribution of peripartum hypoxic events 
to NE is likely very high.3 Across other settings, 
however, a number of peripartum risk factors for 
NE have been identified,4–7 supporting a complex 
multifactorial model of brain injury.
Increasing evidence suggests the critical impor-
tance of a sensitising effect of inflammation in the 
pathogenesis of NE.8 9 In neonatal rodent studies, 
exposure to bacterial endotoxin has been found 
to increase vulnerability of the developing brain 
to injury, with a pathway involving stimulation of 
toll-like receptors, inflammatory responses, chemo-
taxis and cell death.10 Other preclinical studies 
have shown a temporal relationship between 
bacterial endotoxin and brain injury, with both 
sensitising and preconditioning effects seen.11 12 
In clinical studies, factors associated with perinatal 
infection such as maternal fever and prolonged 
rupture of membranes, are associated with NE5–7 
10 13; however, this may be mediated by the direct 
What this study adds?
 ► Perinatal infection and inflammation are 
independent risk factors for neonatal 
encephalopathy in this African population, 
supporting a role in the aetiological pathway 
of term brain injury.
 ► Intrapartum antibiotic use, however, was not 
associated with improved neonatal outcome.
 ► The importance of other intrapartum risk factors 
in this setting is highlighted.
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What is already known on this topic?
 ► Perinatal brain injury is the third leading cause 
of child mortality globally, with some of the 
highest burden seen in low-resource African 
settings.
 ► Preclinical studies suggest infection and 
inflammation can sensitise or precondition the 
term newborn brain to injury.
 ► Understanding which perinatal risk factors are 
associated with neonatal encephalopathy is key 
to developing interventions to prevent newborn 
deaths and disability.
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Figure 1 Diagram showing how infants moved through the study procedures. CRP, C reactive protein; qPCR, quantitative Polymerase Chain 
Reaction.
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effect of hyperthermia itself on the developing brain as opposed 
to any underlying cause.13 Few clinical studies have examined 
the role of specific perinatal infections and inflammation as 
independent risk factors for NE, although an important role is 
hypothesised.14
Understanding which perinatal risk factors are associated 
with NE is key in developing interventions to prevent newborn 
deaths and disability. Despite a high burden of NE in sub-Sa-
haran Africa, the role of infectious comorbidity, such as neonatal 
bacteraemia and chorioamnionitis, and the contribution of other 
risk factors in the aetiology of NE have been poorly defined. 
We conducted an unmatched case–control study among hospi-
tal-born newborns in Uganda aiming to identify risk factors for 
NE in resource-limited settings.
MeThODS AnD MATeRIAlS
Setting
Uganda is a low-income country with a neonatal mortality rate 
of 23 per 1000 live births.15 Mulago National Referral Hospital, 
in the capital Kampala, receives high-risk pregnancies from the 
city and surrounding areas. In 2012, more than 33 000 deliv-
eries occurred on the low-risk (21%) and high-risk (79%) labour 
wards. Fetal monitoring is by intermittent auscultation and 
women are not routinely examined at the start of second stage. 
Assisted deliveries (ventouse or forceps) are rarely performed. 
A fifth of deliveries are by caesarean section. Intravenous fluids, 
antibiotics and oxytocin are available. Neonatal resuscitation, 
performed by midwives, includes oxygen and bag-mask ventila-
tion. Care on the 80-bed special care baby unit (SCBU) includes 
simple continuous positive airway pressure ventilation (not 
mechanical ventilation), intravenous fluids, antibiotics and anti-
seizure medication. Blood gas estimation facilities are not avail-
able.
Study design and recruitment
We conducted an unmatched case–control study between 
September 2011 and October 2012. Written informed parental 
consent was obtained. All term newborns admitted to the SCBU 
were examined for encephalopathy using the Thompson score.16 
Cases were term newborns ≥37 weeks, with NE defined as a 
‘Thompson score’ >5 within 12 hours of birth, as assessed 
by CJT or other study doctors. Neurological assessment was 
performed on recruitment for cases and controls and then 
daily for 5 days (cases only). Encephalopathy was graded (mild, 
moderate or severe) on the most severe day between days 1 and 
5, per modified Sarnat classification,17 a scoring system used to 
grade the severity of hypoxic-ischaemic brain injury. Gestational 
age was assessed using last menstrual period or early obstetric 
ultrasound scan, and if unavailable based on external newborn 
examination.18 Infants were reviewed after discharge at 4–6 
weeks of age to establish survival. Figure 1 describes how case 
and control infants moved through the study.
To reflect all hospital deliveries, controls were recruited in a 
ratio of 79:21 from the high-risk and low-risk wards, respec-
tively. Control mothers and infants were systematically sampled 
from the labour ward admission book. Control infants were 
eligible for recruitment if term with Thompson score <3. Exclu-
sion criteria (cases and controls) included prior antibiotics given 
to the infant (which would invalidate blood culture results), 
mother living >20 km from the hospital, out-born infants and 
no informed written consent. Infants with congenital abnormali-
ties or other concomitant pathology were not excluded.
Data collection
Information from antepartum, intrapartum and postpartum 
periods was collected using structured maternal interviews 
and from clinical records. Postnatal anthropometric measure-
ments on mother (height, weight) and newborns (occipitof-
rontal circumference, birth weight (SECA 336 electronic scales, 
Hamburg, Germany)) were taken.
Maternal and neonatal infection and inflammation
Maternal and neonatal blood was sampled at recruitment (<12 hours 
of delivery). Blood was stored at −80°C. Maternal and neonatal C 
reactive protein (CRP) was batch-tested (COBAS, Roche Diagnos-
tics, Basel, Switzerland). Maternal HIV results were recorded from 
routine hospital testing.19
Blood culture and species-specific bacterial real-time PCR assays 
detected neonatal bacteraemia. Blood cultures (BACTEC) were 
performed for all case infants and for control infants with a clinical 
suspicion of sepsis. Isolated colonies were manually identified. Tech-
niques for species-specific bacterial PCR and blood culture among 
the study cohorts have been published previously.20 Multiplexed 
PCR assays for the detection of bacteria considered pathogenic 
among newborns (group B Streptococcus, Pneumococcus, Staphylo-
coccus aureus, group A streptococcus, Enterobacteriaceae sp) were 
performed on all cases and the first 101 control infants as a compar-
ison group.20 CRP was measured as a marker of inflammation and 
presented according to centiles among control infants.
Placental pathology
Placentas are not routinely collected and stored at Mulago 
Hospital, and we aimed to collect, process and report placental 
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Figure 2 Conceptual framework of preconception, antepartum and intrapartum factors used for the multivariable modelling of risk factors 
for neonatal encephalopathy (NE). A three-phase, causal approach to multivariable modelling, based on a conceptual framework, was used to 
estimate adjusted ORs. First, a model was constructed to include preconception and antepartum variables associated with NE during univariable 
analysis (p<0.05) or where there was strong a priori evidence or biological plausibility for an association. Second, intrapartum variables were 
added to the model to examine the effect on the associations seen between the antepartum and preconception factors and NE and to examine 
the effect of adjusting for these factors on the associations between NE and intrapartum factors. Finally, associations between perinatal infection 
and inflammation exposures and NE were adjusted for peripartum factors found to be independently associated with NE in the second phase of 
the modelling. Factors considered to be a probable consequence of events related to NE, but not themselves causative of NE, that is, emergency 
caesarean section, meconium-stained liquor and poor Apgar scores, were not included in multivariable models.
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histology in a quarter of cases and controls. Placentas were 
collected when infant resuscitation was required (Apgar 
score <6 at 5 min) and for identified potential controls. Whole 
placentas were fixed (10% formalin), sampled according to stan-
dard protocols and processed (SurgPath, Kampala). Slides were 
reported by an experienced perinatal pathologist (NJS) at the 
Camelia Botnar Laboratories, Great Ormond Street Hospital, 
blinded to outcome and all clinical information. Histological 
chorioamnionitis and funisitis were defined according to stan-
dard criteria.21
Statistical analysis
All data were coded (CJT), double-entered (MS Access) and anal-
ysed using Stata V.11.0. Univariable logistic regression was used 
to calculate crude ORs and 95% CIs to identify the independent 
effects of variables. A three-phase, causal approach to multivari-
able modelling was used to estimate adjusted ORs (aORs) using 
the conceptual framework described in figure 2.
Since the proportion of missing data for variables was small 
(<5% for all variables, <1% for most variables), extra cate-
gories were created to represent missing values for the vari-
ables included. Inflammatory factors were defined as maternal 
CRP >90th centile, histological chorioamnionitis, histological 
funisitis, positive neonatal bacteraemia and raised neonatal 
CRP >97th centile. Population attributable fraction was calcu-
lated to assess the contribution of inflammatory factors to NE. 
The sample size of 210 cases and 409 controls ensured at least 
80% power to detect risk factors conferring OR ≥2.5 at a signif-
icance level p<0.05, for main exposures with a prevalence of 
5%–80%.
ReSulTS
During our 13-month recruitment period, 36 926 infants were born 
at Mulago Hospital, from which 210 encephalopathic and 409 
control infants were recruited. Information on the number of babies 
who were considered as potential cases was not available due to 
the high number of babies admitted to the SCBU. For controls, a 
total of 505 mothers of term infants were identified by systemic 
sampling and approached. Of these 81% (409) consented to recruit-
ment (figure 3).
Table 1 shows the early clinical characteristics of case and 
control infants. External signs of a major congenital abnormality 
were uncommon but more frequent in cases (2.9% (6/210) vs 
0.7% (3/408), respectively, p=0.037). Losses to follow-up at 
4 weeks were 1.0% (2/210) of cases vs 3.2% (13/409) of controls 
(p=0.103). Neonatal case fatality (<28 days) was 33.7% (n=70, 
95% CI 27.2% to 40.1%) among encephalopathic infants 
(table 1).
Preconception, antepartum and intrapartum risk factors
In univariable analyses (table 2) case mothers were more likely 
to be primiparous, young, underweight and of short stature, to 
have severe anaemia or hypertension during pregnancy, and 
to be HIV-negative. Cases were more likely to be male, have a 
head circumference >97th centile and non-cephalic presen-
tation. A third of encephalopathic infants were obstructed in 
labour compared with 8% of controls. Augmentation of labour, 
prolonged rupture of membranes, prolonged labour and meco-
nium-stained liquor were all significantly more prevalent among 
cases. Acute intrapartum events were uncommon, but more 
prevalent among cases. No case infant was delivered by elective 
caesarean section. Fetal heart rate monitoring was significantly 
more prevalent among controls. In multivariable analysis one 
antepartum factor (hypertension in pregnancy), two infant factors 
(male sex, non-cephalic presentation) and four intrapartum factors 
(augmentation of labour, no fetal monitoring, acute intrapartum 
event and obstructed labour) were identified as independent risk 
factors for NE (table 2).
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Figure 3 Flow diagram of participants.
Table 1 Early clinical characteristics of case and control infants
Clinical 
characteristics
Cases n=210
n (%)
Controls n=409
n (%) p Value
Apgar 1 min
  ≤3 68/202 (33.7) 2/405 (0.5) <0.0001†
  4–6 116/202 (57.4) 15/405 (3.7)
  ≥7 18/202 (8.9) 388/405 (95.8)
Apgar at 5 min
  ≤3 8/185 (4.3) 1/399 (0.25) <0.0001†
  4–6 126/185 (68.1) 1/399 (0.25)
  ≥7 51/185 (27.6) 397/399 (99.5)
Need for any 
resuscitation
  No 6/162 (3.7) 331/378 (85.1) <0.001
  Yes 156/162 (96.3) 57/378 (15.1)
Clinical features
Grade of 
encephalopathy*
  Mild 25/210 (11.9) –
  Moderate 114/210 (54.3) –
  Severe 71/210 (33.8) –
Absent suck 166/209 (79.4) –
Clinical seizures 104/210 (49.5) –
Comatose 53/210 (25.2) –
Neonatal case fatality 70/208 (33.7) 1/396 (0.3) <0.001
*Encephalopathy graded according to Sarnat & Sarnat.
†chi-squared for trendchi-squared for trend.
Original article
Perinatal infection/inflammation risk factors
The presence of neonatal bacteraemia was examined in 210 cases 
and 105 controls. For controls, quantitative polymerase chain 
reaction (qPCR) was performed among the first 101 recruits. 
In a further 4, qPCR and blood cultures were performed due 
to clinical concerns of early possible severe bacterial infec-
tion; all were negative. No significant differences were seen 
between control infants with and without bacteraemia results 
with respect to demographic or other baseline characteris-
tics (data not shown). The prevalence of pathogenic bacterial 
species among infants with NE was 3.6%, 6.9% and 8.9%, 
with culture, PCR and both tests in combination, respectively.20 
More encephalopathic infants than controls had pathogenic 
bacterial species detected (8.9% vs 2.0%, p=0.028) using 
culture and PCR in combination.20 PCR detected bacteraemia 
in 11 culture-negative encephalopathic infants (3 group B Strep-
tococcus, 1 group A Streptococcus, 1 S. aureus and 6 Enterobac-
teriaceae (2 Enterobacter sp, 1 Pantoea sp, 1 Escherichia coli and 
2 identified only as Enterobacteriaceae species)).20 Three case 
infants were negative on PCR but blood culture was positive for 
S. aureus. Coagulase-negative staphylococcus was considered 
not pathogenic.
Placentas were processed and reported in 28.6% (60/210) of 
cases and 24.9% (102/409) of controls. No significant differ-
ences were seen between mothers with and without placental 
samples with respect to demographic or other baseline charac-
teristics (data not shown). After adjustment for preconception, 
antepartum and intrapartum risk factors (detailed in table 3), 
several markers of infection or inflammation were found to 
be highly significant risk factors for NE, including neonatal 
bacteraemia, histological funisitis and raised maternal and early 
neonatal CRP (table 3).
In NE, neonatal case fatality was not significantly higher for 
infants with early bacteraemia versus those without (44.4% 
(8/18) with bacteraemia vs 32.6%% (62/190) in those without, 
OR 1.65 (0.62–4.39), p=0.32). Intrapartum antibiotic was 
commonly used in cases and controls (17.8% (37/210) vs 
14.0% (57/408), respectively, p=0.213). Among encephalopa-
thic infants, intrapartum antibiotic use was not associated with 
improved neonatal survival (case fatality with intrapartum anti-
biotics 32.4% (12/37) vs 34.3% (58/169) without, p=0.826).
DISCuSSIOn
Few studies have examined perinatal risk factors for NE in 
sub-Saharan Africa. In this Ugandan population, we found that 
maternal and newborn infection and inflammation, based on 
blood cultures, molecular assays and a subset of placentas, are 
independent risk factors for NE, with the strongest associations 
seen with fetal inflammation (funisitis) and early neonatal bacte-
raemia. Neonatal case fatality was not significantly higher for 
infants with NE exposed to neonatal bacteraemia. Intrapartum 
antibiotic use did not improve survival among encephalopathic 
infants. Other potentially modifiable antepartum and intra-
partum risk factors were identified, with many antepartum 
factors mediated by intrapartum events suggesting potential 
large gains with improvements in intrapartum care.
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Table 2 Risk factors associated with neonatal encephalopathy in univariable analysis and after adjustment for preconception, antepartum and 
intrapartum factors
Risk factor
Cases
n (%)
Controls
n (%)
unadjusted OR
(n=620) 95% CI
Adjusted OR‡‡
(n=614) 95% CI
Sociodemographic factors
Socioeconomic group
  High 33/209 (15.8) 82/405 (20.3) 1.00 – 1.00 –
  Medium 131/209 (62.7) 245/405 (60.5) 1.64 0.87 to 3.11 1.52 0.81 to 2.34
  Low 45/209 (21.5) 78/405 (19.3) 1.46 0.83 to 2.47 1.39 0.64 to 3.01
Preconception factors
  Maternal age <20 years 61/210 (29.1) 76/408 (18.6) 1.79 1.21 to 2.64 1.28 0.70 to 2.50
  Maternal weight <50 kg 31/208 (14.9) 34/401 (8.5) 1.89 1.13 to 3.18 0.69 0.32 to 1.61
  Maternal height <150 cm 40/208 (19.2) 44/399 (11.0) 1.92 1.21 to 3.06 1.48 0.73 to 3.00
Antepartum factors
  Primiparity 123/210 (58.6) 183/409 (44.7) 1.75 1.25 to 2.44 1.56 0.86 to 2.84
  ≥4 Antenatal visits 99/210 (47.1) 225/408 (55.2) 0.73 0.52 to 1.01 0.96 0.60 to 1.52
  Previous ‘birth asphyxia’ 20/87 (23.0) 33/226 (14.6) 1.75 0.94 to 3.25 1.27 0.50 to 3.21
  Previous perinatal death 24/87 (27.6) 44/226 (19.5) 1.58 0.89 to 2.80 1.22 0.52 to 2.91
  Severe anaemia during pregnancy* 10/209 (4.8) 5/408 (1.2) 4.05 1.37 to 12.01 4.38 0.97 to 19.82
  Hypertension during pregnancy† 18/210 (8.6) 17/408 (4.2) 2.16 1.09 to 4.28 3.77 1.49 to 9.55
  Maternal HIV-positive 15/210 (7.1) 53/409 (13.0) 0.52 0.28 to 0.94 0.57 0.24 to 1.32
Infant factors
  Male 136/210 (64.8) 196/409 (47.9) 2.00 1.42 to 2.82 2.51 1.55 to 4.07
  Birth weight <2.5 kg 11/209 (5.3) 27/409 (6.6) 0.81 0.39 to 1.67 0.46 0.15 to 1.44
  Birth weight >4.0 kg 12/209 (5.7) 12/409 (2.9) 2.00 0.88 to 4.51 2.17 0.77 to 6.13
  Large head circumference‡ 21/191 (11.0) 12/400 (3.0) 3.99 1.92 to 8.30 2.28 0.59 to 6.22
  Twins 5/210 (2.4) 13/409 (3.2) 0.74 0.26 to 2.11 0.58 0.13 to 2.61
  Non-cephalic presentation 23/209 (11.0) 11/409 (2.7) 4.47 2.14 to 9.37 5.74 2.01 to 16.41
Intrapartum factors
  Augmentation of labour 42/209 (20.1) 43/408 (10·5) 2.13 1.34 to 3.39 2.23 1.17 to 4.23
  No auscultation of fetal heart rate 
during labour
114/208 (54.8) 115/408 (28·2) 3.09 2.18 to 4.38 2.75 1.71 to 4.22
  Prolonged rupture of membranes§ 21/193 (10.9) 15/396 (3·8) 3.10 1.56 to 6.16 2.44 0.90 to 6.60
  Acute intrapartum event¶ 8/210 (3.8) 4/409 (1·0) 4.01 1.19 to 13.47 8.74 1.70 to 45.02
  Obstructed labour** 65/181 (31.9) 33/407 (8·1) 6.35 4.00 to 10.14 3.80 1.96 to 7.36
  Prolonged labour†† 100/190 (52.6) 157/387 (40·6) 1.63 1.15 to 2.31 0.81 0.47 to 1.39
  Meconium-stained liquor 55/121 (45.5) 19/359 (5·3) 14.91 8.31 to 26.75 # –
  Elective caesarean section 0/209 (0.0) 3/409 (0·7) – – # –
  Emergency caesarean section 50/209 (23.9) 56/409 (13·7) 1.98 1.30 to 3.03 # –
*Defined as haemoglobin ≤7 g/dL during pregnancy and documented in the clinical record.
†Defined as systolic blood pressure >140 mm Hg or diastolic >90 mm Hg developing after 20 weeks’ gestation.
‡Defined as >97th centile in the control population (37.9 cm).
§Defined as rupture ≥24 hours.
¶Defined as antepartum haemorrhage, cord prolapse or uterine rupture.
**Defined as labour with no advance of the presenting part despite strong, regular uterine contractions as documented in the intrapartum record.
††Defined as >24 hours in primiparity and >12 hours in multiparity.
‡‡Adjusted for all other variables in the table plus maternal C reactive protein >90th centile and neonatal bacteraemia. Factors considered a consequence of intrapartum events 
(#) were not included in the model.
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In our study, funisitis, or infiltration of the umbilical cord 
with acute fetal inflammatory cells, was a significant risk factor 
for NE; however, the presence of membrane inflammation alone 
(isolated histological chorioamnionitis) was not. The reduced 
sample size of infants with placentas collected (n=162) may 
have been responsible for the lack of significance of the asso-
ciation seen between NE and chorioamnionitis; however, this 
smaller sample size retained more than 80% power to detect 
the associations seen for funisitis. Triggering of the fetal inflam-
matory responses, as evidenced by the presence of funisitis, 
has been associated previously with neurological impairment 
among both term and preterm infants.22–25 A high incidence of 
histological funisitis among infants with NE has been previously 
reported (22%–31%),24 26 with one retrospective observational 
study also finding funisitis to be significantly associated with 
encephalopathy (OR 9.29).24 A recent study from the Neth-
erlands, examining associations between placental pathology 
and pattern of brain injury in NE, found a high incidence of 
histological chorioamnionitis across all patterns of brain injury, 
when compared with healthy term deliveries in a historic 
cohort from the same centre (50% vs 18%, respectively).26 The 
stronger associations with NE seen for histological funisitis, as 
opposed to chorioamnionitis, may imply that activation of the 
fetal inflammatory response is a key event, or that duration of 
exposure, or proximity of inflammation to the fetus, may be 
important.
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Table 3 Univariable and adjusted analyses of perinatal infection/inflammation risk factors and between inflammatory and probable asphyxial 
factors
univariable analysis Multivariable analysis
Risk factor
Case
n (%)
Control
n (%)
unadjusted
OR 95% CI
Adjusted
OR† 95% CI
Maternal and newborn C reactive protein (CRP)
Maternal CRP
  <10th centile (≤4.7 mg/L) 3/205 (1.5) 40/407 (9.8) 1.00 – 1.00 –
  10th–90th centile (4.7–86.6 mg/L) 131/205 (63.9) 327/407 (80.3) 5.34 1.62 to 17.57 5.21 1.23 to 22.06
  >90th centile (>86.6 mg/L) 71/205 (34.6) 40/407 (9.8) 23.67 6.87 to 81.42 37.16 7.86 to 175.66
Neonatal CRP
  <90th centile (<6.6 mg/L) 159/205 (77.6) 359/398 (90.2) 1.00 – 1.00 –
  90th–97th centile (6.6–31.7 mg/L) 29/205 (14.2) 28/398 (7.0) 2.34 1.35 to 4.06 3.17 1.57 to 6.41
  >97th centile (>31.7 mg/L) 17/205 (8.3) 11/398 (2.8) 3.49 1.60 to 7.62 9.52 3.33 to 27.21
Maternal and newborn infection and inflammation
Neonatal bacteraemia* 18/210 (8.6) 2/105 (1.9) 4.83 1.10 to 21.22 8.67 1.51 to 49.74
Histological chorioamnionitis alone (no 
funisitis)
10/60 (16.7) 11/102 (10.8) 2.33 0.91 to 5.98 3.20 0.66 to 15.52
Histological funisitis (with 
chorioamnionitis)
16/60 (26.7) 4/102 (3.9) 10.24 3.19 to 32.82 11.80 2.19 to 63.45
*Defined as blood culture and/or species-specific bacterial quantitative Polymerase Chain Reaction (qPCR) for an organism known to be pathogenic among term newborns.
†Adjusted for preconception/antepartum factors in table 2, plus intrapartum factors (augmentation of labour, prolonged labour, obstructed labour and acute intrapartum event).
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Both a sensitising and preconditioning role of bacterial endo-
toxin on the effect of hypoxia-ischaemia on the immature brain 
have been seen in animal models, but supporting clinical data 
are limited. Our study provides evidence of an important role 
for early newborn bacteraemia in NE in humans, with an eight-
fold increase in odds of NE. Early neonatal infection did not 
significantly increase the odds of death among infants with NE, 
although the small numbers of infants in the infection-exposed 
group (n=18) may have reduced the ability to detect a true 
difference. Our findings are supported, however, by a US study, 
examining MRI in predicting outcome after NE, that reported a 
similar prevalence of sepsis and an increase in adverse neurode-
velopmental outcomes, but not death, among encephalopathic 
infants with sepsis.27 Despite the administration of intrapartum 
antibiotics in almost a fifth of encephalopathy cases in our study, 
antibiotics did not improve survival. This lack of effect of antibi-
otic therapy is consistent with findings from the ORACLE trial, 
which examined neonatal outcomes after preterm rupture of 
membranes.28 29 Although our infants were not cooled, our inci-
dence of sepsis was comparable to many hypothermia trials from 
high-income settings (5%–14%).30
Other studies from both low-income and high-income settings 
have examined this ‘dual hit’ hypothesis of infection and hypox-
ia-ischaemia. A population-based study from South Asia also 
reported significantly increased odds of early neonatal death 
due to intrapartum asphyxia in newborns exposed to prolonged 
rupture of membranes (aOR 1.52; 1.15–2.02),31 a predisposing 
factor for intrauterine infection and early newborn bacteraemia. 
Previous studies in high-income settings have shown a high preva-
lence of inflammatory indicators among infants with NE,32 and a 
combination of antenatal infection and a potentially birth-asphyx-
iating condition can dramatically increase the risk of cerebral palsy 
(OR 78.0) when compared with either alone.33 In our study, posi-
tive dose-related associations were seen between raised maternal 
and neonatal CRP, an acute phase reactant and NE. Previous 
studies have shown associations between a raised neonatal CRP 
and a number of neonatal condition including infection, perinatal 
asphyxia and meconium aspiration,34 and so an association with 
maternal and newborn infection cannot be assumed.
In univariable analysis, we identified several other peripartum 
risk factors for NE. Maternal and infant factors included prim-
iparity, young maternal age, low maternal weight or stature, 
complications during pregnancy (hypertension, severe anaemia) 
and large infant head circumference. However, these antepartum 
factors did not significantly improve the fit of the data after adjust-
ment for intrapartum events, suggesting that their association 
with NE is likely mediated by increasing the risk of intrapartum 
complication. However, even after adjustment, male infants and 
those of non-cephalic presentation remained significant risk 
factors for NE. Although an acute intrapartum event signifi-
cantly increased the risk of NE, such events were uncommon, 
and other potentially modifiable factors such as hypertension in 
pregnancy, lack of fetal monitoring, non-cephalic presentation 
and obstructed labour contributed to a higher proportion of 
cases of NE in our population. A high demand for services in the 
face of low midwife to mother staffing ratios, lack of equipment 
and delays in providing rapid obstetric intervention may have 
been substantial contributing factors in our setting. Prioritising 
effective risk assessment and intrapartum care for women and 
babies delivering in healthcare facilities in low-resource settings 
has the potential to substantially reduce neonatal risk.35
There were limitations to this study. Placental sampling was 
performed in only a quarter of women, and although sampling 
appeared non-differential all bias cannot be excluded, and 
power to detect associations for placental variables was reduced. 
Recruitment of participants from a high-risk referral centre may 
explain the high rates of chorioamnionitis seen; however, this 
would have led to a conservative estimate of all ORs. Although 
we performed species-specific bacterial PCR in conjunction with 
neonatal blood culture to strengthen the diagnosis of neonatal 
bacteraemia, we still cannot exclude underdiagnosis. The 
majority of control infants did not show clinical signs of sepsis, 
and loss to follow-up rates in both groups were low. We cannot 
exclude all selection and recall bias, although rigorous verifica-
tion with hospital records and comprehensive staff interview 
training aimed to minimise this.
In summary, perinatal infection and inflammation are indepen-
dent risk factors for NE in this low-resource setting, supporting 
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a role in the aetiological pathway of term brain injury. Intra-
partum antibiotic administration did not mitigate again adverse 
outcomes. The importance of intrapartum risk factors in this 
sub-Saharan African setting is highlighted.
Acknowledgements We thank the parents, guardians and children who 
participated in the study; the ABAaNA study team for their dedicated contribution to 
data collection and care of study participants; and Jamiir Mugalu, Jolly Nankunda, 
Natasha Nyombi, Flaviah Namiiro, Anita and all on the special care unit and labour 
ward at Mulago Hospital for their support. Thank you also to the MRC/UVRI Uganda 
Research Unit on AIDS, Entebbe and the Wellcome Bloomsbury Centre, LSHTM 
and the Camelia Botnar Laboratories at Great Ormond Street Hospital for their 
administrative and laboratory support.
Contributors CJT, JJK, NK, NJS, DP, KAH, AME and NJR designed the study and 
were involved in data interpretation and report writing. CJT implemented and led 
the study. Data analysis was conducted by CJT and BAW, ELW and JJK provided 
statistical support. CJT, MN, MS, MM, NN, IO, EDM and PN participated in data 
collection. CJT, PN and KAH performed the molecular assays. MN, JM, AME and NJR 
provided logistical support. All authors reviewed and approved the final version. All 
authors had full access to all of the data (including statistical reports and tables) in 
the study and can take responsibility for the integrity of the data and the accuracy 
of the data analysis. CJT affirms that the manuscript is an honest, accurate and 
transparent account of the study being reported; that no important aspects of the 
study have been omitted; and that any discrepancies from the study as planned have 
been explained.
Funding The study was funded by a Wellcome Trust Bloomsbury Clinical Fellowship 
in International Health to CT (094016/Z/10/Z). The Wellcome Trust had no role in the 
design and conduct of the study; collection, management, analysis and interpretation 
of the data; preparation, review or approval of the manuscript; and decision to 
submit the manuscript for publication.
Competing interests None declared.
ethics approval London School of Hygiene & Tropical Medicine, Uganda Virus 
Research Institute and Uganda National Council of Science & Technology.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement Data from this study will be made available for further 
research to anyone with an interest in relevant further study, subject to proper 
acknowledgements and on contacting the corresponding author.
Open Access This is an Open Access article distributed in accordance with the 
terms of the Creative Commons Attribution (CC BY 4.0) license, which permits 
others to distribute, remix, adapt and build upon this work, for commercial use, 
provided the original work is properly cited. See: http:// creativecommons. org/ 
licenses/ by/ 4. 0/
© Article author(s) (or their employer(s) unless otherwise stated in the text of the 
article) 2017. All rights reserved. No commercial use is permitted unless otherwise 
expressly granted.
RefeRences
 1 Liu L, Oza S, Hogan D, et al. Global, regional, and national causes of child mortality 
in 2000-13, with projections to inform post-2015 priorities: an updated systematic 
analysis. Lancet 2015;385:430–40.
 2 Lee AC, Kozuki N, Blencowe H, et al. Intrapartum-related neonatal encephalopathy 
incidence and impairment at regional and global levels for 2010 with trends from 
1990. Pediatr Res 2013;74(Suppl 1):50–72.
 3 Lawn JE, Lee AC, Kinney M, et al. Two million intrapartum-related stillbirths and 
neonatal deaths: where, why, and what can be done? Int J Gynaecol Obstet 
2009;107(Suppl 1):S5–S19.
 4 Badawi N, Kurinczuk JJ, Keogh JM, et al. Antepartum risk factors for newborn 
encephalopathy: the Western Australian case-control study. BMJ 1998;317:1549–53.
 5 Badawi N, Kurinczuk JJ, Keogh JM, et al. Intrapartum risk factors for newborn 
encephalopathy: the Western Australian case-control study. BMJ 1998;317:1554–8.
 6 Ellis M, de L Costello AM. Antepartum risk factors for newborn encephalopathy. 
Intrapartum risk factors are important in developing world. BMJ 1999;318:1414.
 7 Martinez-Biarge M, Diez-Sebastian J, Wusthoff CJ, et al. Antepartum and intrapartum 
factors preceding neonatal hypoxic-ischemic encephalopathy. Pediatrics 2013;132:e9
52–e959.
 8 Fleiss B, Tann CJ, Degos V, et al. Inflammation-induced sensitization of the brain in 
term infants. Dev Med Child Neurol 2015;57(Suppl 3):17–28.
 9 Hagberg H, Mallard C, Ferriero DM, et al. The role of inflammation in perinatal brain 
injury. Nat Rev Neurol 2015;11:192–208.
 10 Stridh L, Mottahedin A, Johansson ME, et al. Toll-like receptor-3 activation 
increases the vulnerability of the neonatal brain to hypoxia-ischemia. J Neurosci 
2013;33:12041–51.
 11 Eklind S, Mallard C, Arvidsson P, et al. Lipopolysaccharide induces both a primary 
and a secondary phase of sensitization in the developing rat brain. Pediatr Res 
2005;58:112–6.
 12 Stevens SL, Leung PY, Vartanian KB, et al. Multiple preconditioning paradigms 
converge on interferon regulatory factor-dependent signaling to promote tolerance to 
ischemic brain injury. J Neurosci 2011;31:8456–63.
 13 Peebles D. Intrauterine infection and perinatal brain injury. Royal College of Obstetrics 
& Gynecology: Scientific Advisory Committee opinion paper, 2007.
 14 Nelson KB, Penn AA. Is infection a factor in neonatal encephalopathy? Arch Dis Child 
Fetal Neonatal Ed 2015;100:F8–F10.
 15 UNICEF. Levels and trends in child mortality, report. New York, USA: UNICEF, WHO, 
The World Bank, United Nations, 2013.
 16 Thompson CM, Puterman AS, Linley LL, et al. The value of a scoring system for hypoxic 
ischaemic encephalopathy in predicting neurodevelopmental outcome. Acta Paediatr 
1997;86:757–61.
 17 Sarnat HB, Sarnat MS. Neonatal encephalopathy following fetal distress. A clinical and 
electroencephalographic study. Arch Neurol 1976;33:696–705.
 18 Parkin JM, Hey EN, Clowes JS. Rapid assessment of gestational age at birth. Arch Dis 
Child 1976;51:259–63.
 19 Namukwaya Z, Mudiope P, Kekitiinwa A, et al. The impact of maternal highly active 
antiretroviral therapy and short-course combination antiretrovirals for prevention of 
mother-to-child transmission on early infant infection rates at the Mulago national 
referral hospital in Kampala, Uganda, January 2007 to May 2009. J Acquir Immune 
Defic Syndr 2011;56:69–75.
 20 Tann CJ, Nkurunziza P, Nakakeeto M, et al. Prevalence of bloodstream pathogens is 
higher in neonatal encephalopathy cases vs. controls using a novel panel of real-time 
PCR assays. PLoS One 2014;9:e97259.
 21 H sn F. Pathology of placenta. Philadelphia, USA: Elsevier Limited, 2007.
 22 Redline RW. Inflammatory response in acute chorioamnionitis. Semin Fetal Neonatal 
Med 2012;17:20–5.
 23 Redline RW. Inflammatory responses in the placenta and umbilical cord. Semin Fetal 
Neonatal Med 2006;11:296–301.
 24 Hayes BC, Cooley S, Donnelly J, et al. The placenta in infants >36 weeks gestation 
with neonatal encephalopathy: a case control study. Arch Dis Child Fetal Neonatal Ed 
2013;98:F233–F239.
 25 Lau J, Magee F, Qiu Z, et al. Chorioamnionitis with a fetal inflammatory response 
is associated with higher neonatal mortality, morbidity, and resource use than 
chorioamnionitis displaying a maternal inflammatory response only. Am J Obstet 
Gynecol 2005;193:708–13.
 26 Harteman JC, Nikkels PG, Benders MJ, et al. Placental pathology in full-term infants 
with hypoxic-ischemic neonatal encephalopathy and association with magnetic 
resonance imaging pattern of brain injury. J Pediatr 2013;163:968–75.
 27 Jenster M, Bonifacio SL, Ruel T, et al. Maternal or neonatal infection: association with 
neonatal encephalopathy outcomes. Pediatr Res 2014;76:93–9.
 28 Kenyon SL, Taylor DJ, Tarnow-Mordi W. Broad-spectrum antibiotics for preterm, 
prelabour rupture of fetal membranes: the ORACLE I randomised trial. ORACLE 
Collaborative Group. Lancet 2001;357:979–88.
 29 Kenyon SL, Taylor DJ, Tarnow-Mordi W. Broad-spectrum antibiotics for spontaneous 
preterm labour: the ORACLE II randomised trial. ORACLE Collaborative Group. Lancet 
2001;357:989–94.
 30 Jacobs SE, Berg M, Hunt R, et al. Cooling for newborns with hypoxic ischaemic 
encephalopathy. Cochrane Database Syst Rev 2013:Cd003311.
 31 Iwamoto A, Seward N, Prost A, et al. Maternal infection and risk of intrapartum death: 
a population based observational study in South Asia. BMC Pregnancy Childbirth 
2013;13:245.
 32 Nelson KB, Bingham P, Edwards EM, et al. Antecedents of neonatal encephalopathy in 
the Vermont Oxford Network Encephalopathy Registry. Pediatrics 2012;130:878–86.
 33 Nelson KB, Grether JK. Potentially asphyxiating conditions and spastic cerebral palsy 
in infants of normal birth weight. Am J Obstet Gynecol 1998;179:507–13.
 34 Hofer N, Zacharias E, Müller W, et al. An update on the use of C-reactive protein 
in early-onset neonatal sepsis: current insights and new tasks. Neonatology 
2012;102:25–36.
 35 Bhutta ZA, Das JK, Bahl R, et al. Can available interventions end preventable 
deaths in mothers, newborn babies, and stillbirths, and at what cost? Lancet 
2014;384:347–70.
group.bmj.com on October 6, 2017 - Published by http://fn.bmj.com/Downloaded from 
study
encephalopathy: an unmatched case-control 
Perinatal risk factors for neonatal
Jennifer J Kurinczuk, Alison M Elliott and Nicola J Robertson
Peebles, Margaret Musoke, Kathryn A Harris, Neil J Sebire, Nigel Klein,
Sewegaba, Emily L Webb, Ibby Oke, Emmanuel Derek Mutuuza, Donald 
Cally J Tann, Margaret Nakakeeto, Barbara A Willey, Margaret
 published online August 5, 2017Arch Dis Child Fetal Neonatal Ed 
 http://fn.bmj.com/content/early/2017/08/05/archdischild-2017-312744
Updated information and services can be found at: 
These include:
References
 #BIBL
http://fn.bmj.com/content/early/2017/08/05/archdischild-2017-312744
This article cites 31 articles, 10 of which you can access for free at: 
Open Access
http://creativecommons.org/licenses/by/4.0/
use, provided the original work is properly cited. See: 
others to distribute, remix, adapt and build upon this work, for commercial
the Creative Commons Attribution (CC BY 4.0) license, which permits 
This is an Open Access article distributed in accordance with the terms of
service
Email alerting
box at the top right corner of the online article. 
Receive free email alerts when new articles cite this article. Sign up in the
Collections
Topic Articles on similar topics can be found in the following collections 
 (63)Open access
Notes
http://group.bmj.com/group/rights-licensing/permissions
To request permissions go to:
http://journals.bmj.com/cgi/reprintform
To order reprints go to:
http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
group.bmj.com on October 6, 2017 - Published by http://fn.bmj.com/Downloaded from 
